SIC 2834 – Pharmaceutical Preparations
Valuation | |
---|---|
Market Cap ($M) | 55.09 |
Enterprise Value ($M) | 57.43 |
Book Value ($M) | -4.87 |
Book Value / Share | -0.00 |
Price / Book | -11.30 |
NCAV ($M) | -4.94 |
NCAV / Share | -0.00 |
Price / NCAV | -11.15 |
Profitability (mra) | |
---|---|
Return on Invested Capital (ROIC) | n/a |
Return on Assets (ROA) | -3.15 |
Return on Equity (ROE) | n/a |
Liquidity (mrq) | |
---|---|
Quick Ratio | 0.04 |
Current Ratio | 0.08 |
Balance Sheet (mrq) ($M) | |
---|---|
Current Assets | 0.27 |
Assets | 0.33 |
Liabilities | 5.21 |
Debt | n/a |
Equity | n/a |
Income Statement (mra) ($M) | |
---|---|
Revenue | 0.00 |
Operating Income | 0.00 |
Net Income | 0.00 |
Earnings Per Share Basic And Diluted | n/a |
Cash Flow Statement (mra) ($M) | |
---|---|
Cash From Operations | 0.00 |
Cash from Investing | 0.00 |
Cash from Financing | 0.00 |
(click for more detail) |
Top 13F Investors | Shares (1000) |
Change (%) |
Value ($1000) |
Change (%) |
---|---|---|---|---|
(click for more detail) |
Date | Insider Trades | Code | Shares | Value |
---|---|---|---|---|
(click for more detail) |
Similar Companies | |
---|---|
AAVXF – ABIVAX Société Anonyme | ABCZF – Abcam Limited |
Financial data and stock pages provided by
Fintel.io